Pearson v. Dept. of Health and Human Services , 1999 U.S. App. LEXIS 464 (1999)

Is the FDA rule prohibiting the use of disclaimers, and instead outright prohibiting product labeling that is not supported by significant scientific research, an unconstitutional prior restraint...


The Court of Appeals held that the FDA practice was unconstitutional. The standard employed by the agency was not defined by the agencies rules, making it unclear to applicants what level of scientific agreement was required to support a nutritional supplement health claim. By requiring "significant agreement" the FDA prohibited claims that were debatable, or only supported by marginal scientific agreement. The supplements Pearson was attempting to label had been in the marketplace for a long time and had been proven safe. The FDA contended that the evidence, while supported by an adequate amount of research, did not present a high enough level of agreement about the truth of the claims. Pearson claimed, and the court agreed, that a disclaimer could allow the supplement to represent the degree of support the statements had from scientific literature, while expressing the FDA's lack of support for the claim. Because the FDA's process did not represent the least restrictive method of accomplishing a legitimate government restriction of a fundamental right, it was unconstitutional. The court deferred to the FDA on the precise wording of any disclaimer.

Full case and case summary also available online at:

LOADING PDF: If there are any problems, click here to download the file.

Reference Info:Federal, D.C. Circuit, D.C. | United States

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Babener & Associates | Attorney Advertising

Written by:


Babener & Associates on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.